Search Results - "pharmacogenetics"

EFFECT OF GENES SLCO1B1 AND MDR1 POLYMORPHISM ON ATORVASTATIN PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: RESULTS OF PILOT PHARMACOGENETICS STUDY by A. V. Semenov, D. A. Sichev, V. G. Kukes

Connect to this object online.

Characterization of CYP3A pharmacogenetic variation in American Indian and Alaska Native communities, targeting CYP3A4*1G allele function by Alison E. Fohner, Rachel Dalton, Kasse Skagen, Konner Jackson, Katrina G. Claw, Scarlett E. Hopkins, Renee Robinson, Burhan A. Khan, Bhagwat Prasad, Erin G. Schuetz, Deborah A. Nickerson, Timothy A. Thornton, Denise A. Dillard, Bert B. Boyer, Kenneth E. Thummel, Erica L. Woodahl

Connect to this object online.

The use of oral suspension and rationally prescribing alternatives may be supplemental to the implementation of clopidogrel new algorithm comprising CYP2C19 pharmacogenetics and drug interactions by Chen M, Zhou Q

Connect to this object online.

Recipient rs1045642 Polymorphism Is Associated With Office Blood Pressure at 1-Year Post Kidney Transplantation: A Single Center Pharmacogenetic Cohort Pilot Study by Yassine Bouatou, Yassine Bouatou, Ludwig Stenz, Belen Ponte, Serge Ferrari, Ariane Paoloni-Giacobino, Karine Hadaya, Karine Hadaya

Connect to this object online.

Stated Preferences for Attributes of a CYP2C19 Pharmacogenetic Test Among the General Population Presented with a Hypothetical Acute Coronary Syndrome Scenario by Bereza BG, Coyle D, So DY, Kadziola Z, Wells G, Grootendorst P, Papadimitropoulos EA

Connect to this object online.

Role of Protein-Protein Interactions in Metabolism: Genetics, Structure, Function by Michel Kranendonk

Subjects: “…Pharmacogenetics…”
DOAB: download the publication
DOAB: description of the publication

Role of Protein-Protein Interactions in Metabolism: Genetics, Structure, Function, 2nd Edition by Michel Kranendonk

Subjects: “…Pharmacogenetics…”
DOAB: download the publication
DOAB: description of the publication

Pharmacogenetic testing revisited: 5′nuclease real-time polymerase chain reaction test panels for genotyping CYP2D6 and CYP2C19 by Larsen JB, Rasmussen JB

Connect to this object online.

Impact of Population and Pharmacogenetics Variations on Efavirenz Pharmacokinetics and Immunologic Outcomes During Anti-Tuberculosis Co-Therapy: A Parallel Prospective Cohort Study in Two Sub-Sahara African Populations by Sabina Mugusi, Sabina Mugusi, Abiy Habtewold, Eliford Ngaimisi, Wondwossen Amogne, Getnet Yimer, Omary Minzi, Eyasu Makonnen, Eyasu Makonnen, Christopher Sudfeld, Jürgen Burhenne, Eleni Aklillu

Connect to this object online.

Precision Medicine Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy

Subjects: “…pharmacogenetic testing…”
DOAB: download the publication
DOAB: description of the publication

Pharmacogenetic Associations Between Atazanavir/UGT1A1*28 and Efavirenz/rs3745274 (CYP2B6) Account for Specific Adverse Reactions in Chilean Patients Undergoing Antiretroviral Therapy by Daniela Poblete, Fernando Bernal, Gabriel Llull, Sebastian Archiles, Patricia Vasquez, Leonardo Chanqueo, Nicole Soto, María A. Lavanderos, María A. Lavanderos, Luis A. Quiñones, Luis A. Quiñones, Nelson M. Varela, Nelson M. Varela

Connect to this object online.

Pharmacogenetic analysis of the effects of polymorphisms in <it>APOE</it>, <it>IDE </it>and <it>IL1B </it>on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; a randomized, double-blind, placebo-controlled study by Poirier Judes, Henderson Samuel T

Connect to this object online.

IL-6 &minus;572C>G and CARD8 304T>A Genetic Polymorphisms are Associated with the Absolute Neutrophil Count in Patients with Hematological Malignancies Under Chemotherapy: An Application of Multilevel Models to a Preliminary Pharmacogenetic Study by Martinez MF, Alveal E, Soto TG, Bustamante EI, Ávila F, Bangdiwala SI, Flores I, Benavides C, Morales R, Varela NM, Quiñones LA

Connect to this object online.

Afro-Latin American Pharmacogenetics of <i>CYP2D6</i>, <i>CYP2C9</i>, and <i>CYP2C19</i> in Dominicans: A Study from the RIBEF-CEIBA Consortium by Mariela Guevara, Fernanda Rodrigues-Soares, Carla González de la Cruz, Fernando de Andrés, Ernesto Rodríguez, Eva Peñas-Lledó, Adrián LLerena, CEIBA Consortium of the Ibero-American Network of Pharmacogenetics and Pharmacogenomics RIBEF

Connect to this object online.

Pharmacogenomics and Personalized Medicine

Subjects: “…pharmacogenetics study…”
DOAB: download the publication
DOAB: description of the publication

Pharmacogenomics From Basic Research to Clinical Implementation

Subjects: “…pharmacogenetics…”
DOAB: download the publication
DOAB: description of the publication

A Robust and Fast/Multiplex Pharmacogenetics Assay to Simultaneously Analyze 17 Clinically Relevant Genetic Polymorphisms in <i>CYP3A4</i>, <i>CYP3A5</i>, <i>CYP1A2</i>, <i>CYP2C9</i>, <i>CYP2C19</i>, <i>CYP2D6</i>, <i>ABCB1,</i> and <i>VKORC1</i> Genes by Camille Tron, Régis Bouvet, Marie-Clémence Verdier, Fabien Lamoureux, Benjamin Hennart, Christèle Dubourg, Eric Bellissant, Marie-Dominique Galibert

Connect to this object online.

Psychoneurobiology Research and Personalized Treatment of Schizophrenia

Subjects: “…pharmacogenetics…”
DOAB: download the publication
DOAB: description of the publication

Genetics of Prader-Willi syndrome

Subjects: “…pharmacogenetic testing…”
DOAB: download the publication
DOAB: description of the publication

Personalized Medicine for Parkinson's Disease New Concepts and Future of Individualized Management

Subjects: “…pharmacogenetic…”
DOAB: download the publication
DOAB: description of the publication